Sylvester Comprehensive Cancer Center

UM/Sylvester Welcomes Top Cancer Researchers


Please join us for the third annual Landon – American Association for Cancer Research (AACR) prize lecture at the University of Miami Sylvester Comprehensive Cancer Center. Kirk A. Landon is a member of the Merrick Society of the University. His support of UM/Sylvester makes this unique annual presentation of leading cancer research possible.

Tony Hunter, Ph.D., professor of molecular and cell biology at The Salk Institute for Biological Studies in La Jolla, Calif., has been awarded the Kirk A. Landon-AACR Prize for Basic Cancer Research. Since 1979, Hunter has been investigating the molecular signals in the regulation, development, and growth of cells and what happens when this process goes awry in cancer. His work has led to intensive study of tyrosine kinases worldwide which have yielded several investigational anti-cancer drugs and one FDA-approved therapy – Gleevec, for treatment of chronic myelogenous leukemia.

Raymond N. DuBois, M.D., Ph.D., the Hortense B. Ingram Professor of Molecular Oncology and the Vanderbilt-Ingram Cancer Center’s associate director for cancer prevention, control and population-based research, in Nashville, Tenn., has been awarded the Dorothy P. Landon-AACR Prize for Translational Cancer Research. He is being honored for his contributions to the understanding of the role of an enzyme called cyclooxygenase-2, or COX-2, in cancer. Dr. DuBois was the first to report the link between COX-2 and colon cancer, which set in motion later work that defined potential mechanisms and chemopreventive strategies to inhibit this enzyme’s activity.

Each recipient receives $200,000 from the Landon Foundation to further their work. Both honorees will meet with graduate and post-doctoral students in an intimate question and answer session Wednesday, January 19, from 9 a.m. until noon. Then Hunter and DuBois will be joined by UM/Sylvester physicians and scientists for a discussion of novel research from noon until 1:30 p.m. Free valet parking is available to members of the news media at UM/Sylvester, on NW 12 Avenue immediately north of NW 14 Street.

It is the goal of both the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research to bring heightened public attention to landmark achievements in the continuing effort to prevent and cure cancer. The awards recognize outstanding scientists who have made seminal basic and translational cancer research discoveries at the cutting edge of scientific novelty and significance, which have accelerated progress against cancer and have implications for future discoveries and contributions to cancer research.

What: The Third Annual Landon – AACR Prize Lecture

When: Wednesday, January 19

9 a.m. – noon Dr. Hunter and Dr. Dubois visit with M.D., Ph.D., and postdoctoral students
Noon – 1:30 p.m. W. Jarrard Goodwin, M.D., F.A.C.S., director of UM/Sylvester, R. Kirk Landon, president of the Landon Foundation, Margaret Foti, Ph.D., M.D., (h.c.), CEO of the AACR, Dr. Hunter and Dr. Dubois

Where: UM/Sylvester conference room, #1301, near patient registration upstairs

About UM/Sylvester

UM/Sylvester was founded in 1992 to provide comprehensive cancer services and today serves as the hub for cancer-related research, diagnosis, and treatment at the University of Miami School of Medicine. UM/Sylvester handles more than 1,100 inpatient admissions annually, performs 2,800 surgical procedures, and treats 2,900 new cancer patients. All UM/Sylvester physicians are on the faculty of the University of Miami School of Medicine, South Florida’s only academic medical center. In addition, UM/Sylvester physicians and scientists are engaged in more than 150 clinical trials and receive more than $30 million annually in research grants. UM/Sylvester at Deerfield Beach recently opened to better meet the needs of residents of Broward and Palm Beach Counties. This 10,000 square-foot facility at I-95 and S.W. 10th Street offers appointments with physicians from six cancer specialties, complementary therapies from the Courtelis Center, and education and outreach events.

About the AACR

Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 29,000 laboratory, translational and clinical scientists engaged in cancer research in the United States, and more than 60 other countries around the world. AACR’s mission is to accelerate the prevention and cure of cancer through research, education, communication and collaboration. Its principal activities include the publication of five of the most prestigious peer-reviewed scientific journals that span the spectrum of science in the international cancer field — Cancer Research, Molecular Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, and Cancer Epidemiology Biomarkers and Prevention. The Annual Meeting of the AACR, as well as the specialty meetings, special conferences, and international meetings, attract professionals from all sectors of the cancer community to share their latest research findings and cover timely subjects.

E-mail a Friend